The Cook Medical clinical specialist team is here to provide training for your vascular access needs.
Over the past six years, Cook Medical has assembled a highly qualified clinical specialist team. Comprised of four nursing professionals with a combined 114 years of clinical nursing experience, the team was created to help educate our customers about Cook Medical vascular access products and how to best use them to provide excellent patient care.
Team members Jarred Olson, Linda Burns, Diana Melton, and Jon Jacobs visit hospitals throughout the United States and Canada, providing education and training on PICC placement and other vascular access device procedures. They also frequently give talks at regional and national vascular access meetings. Because our clinical specialists are practicing nurses who regularly spend time working in a clinical setting, they are familiar with the challenges faced by nurses.
“Our number one focus is patient care,” says team member Jon Jacobs. “When we go to a hospital to provide training, we work closely with teams there to assess their needs and always try to provide the training and education they need to best care for their patients.”
One of the most challenging issues that our clinical specialists help address is preventing catheter-related and central line-associated bloodstream infections (CRBSIs/CLABSIs) in hospitals. To help lower CLABSI/CRBSI rates, Cook Medical offers Cook Spectrum® catheters, which are impregnated with the antibiotics minocycline and rifampin. When combined with maximal sterile barrier precautions, Spectrum technology provides proven protection against CRBSIs.
Learn more about how bloodstream infections hurt patients and hospitals.
To learn more about Cook Medical’s clinical specialist team and to discuss training needs, e-mail us at firstname.lastname@example.org.
 Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med. 1997;127(4):267-274.